TOME-Logo-RGB.png
Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform
12. Dezember 2023 07:57 ET | Tome Biosciences
Tome Biosciences launches with over $200 million in funding to advance programmable genomic integration (PGI).
DBMR Logo.png
Genomic Medicine Market is Probable to Influence the Value of USD 75.67 Billion by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Analysis
16. Mai 2023 04:30 ET | Data Bridge Market Research
BOSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research's latest report, "Genomic Medicine Market" provides a thorough analysis of growth strategies, drivers, opportunities, key...
Featured Image for Experimental Biology and Medicine
Genomic transposable elements modify the progression of Parkinson's disease
08. November 2022 10:00 ET | Experimental Biology and Medicine
WASHINGTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 18, September, 2022) improves our understanding of genomic...
OpGen.jpg
U.S. Patent Allowed Covering Acuitas Lighthouse® Software
23. Oktober 2019 07:30 ET | OpGen, Inc.
GAITHERSBURG, Md., Oct. 23, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that the United States Patent and Trademark Office (the “USPTO”) has allowed a key OpGen patent...
OpGen.jpg
OpGen Provides update on Curetis Group’s R&D Collaboration
18. September 2019 07:30 ET | OpGen, Inc.
Curetis R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdbCollaborator to fund R&D and obtains option to license ARESdb and ARES Technology...
OpGen.jpg
OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress
08. September 2016 07:30 ET | OpGen, Inc.
GAITHERSBURG, Md., Sept. 08, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will participate in the World Anti-Microbial Resistance Congress being held September 8-9 in...
Elsevier Publishes Medical Epigenetics, New Landmark Volume in Translational Epigenetics Series
14. Juni 2016 04:00 ET | Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - June 14, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of Medical...